Skip to main content

A 5784 — New Jersey

Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Introduced 222 session General Assembly

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • A 5784 is a bill in the New Jersey General Assembly, 222 session.
  • Sponsored by Freiman, Roy.
  • Current status: introduced.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Freiman, Roy

Source: Open States. Last checked November 9, 2026. How we keep this accurate ›